Non-AIDS comorbidities account for significant morbidity/mortality in persons with HIV (PWH). The gastrointestinal tract contributes to systemic immune dysfunction. We assessed associations between detectable rectal tissue (RT) HIV-RNA with 1) systemic inflammatory and hypercoagulation biomarkers and 2) presence of replication-competent virus.
Treatment-naïve PWH initiating dolutegravir-based antiretroviral therapy (ART) underwent blood and RT sampling pre-ART (wk 0) and post-ART (wk 2, 6, 12) between 2/2015 and 9/2019 (NCT 02924389). Plasma and RT HIV-1 RNA was quantitated (Abbott Real-Time HIV-1 Assay; limit <40 c/mL or c/gram). Modified quantitative viral outgrowth assay (QVOA) were performed on a subset of RT samples. Plasma biomarkers (CRP, sCD163, IL-6, TNF-alpha, D-Dimer) were measured by ELISA. Linear regression models were created with each biomarker as the dependent variable and RT suppression status (suppressor vs non-suppressor), biopsy wk (0, 2, 6, 12), and RT suppression status*week as independent variables. Models included random intercept for the participant with a variance components covariance structure.
Fourteen participants (71% male; 86% Black, non-Hispanic) contributed 37 paired plasma/RT samples. Median age was 37 years. Absolute CD4 count was 211 cells/mm3. Thirteen of 14 participants achieved plasma virologic suppression at median Wk 6 but only 5/14 achieved RT virologic suppression at any-time-point. Baseline RT HIV RNA and time to plasma virologic suppression were similar for both groups. Modified QVOA was performed on 11 RT samples with detectable HIV RNA; 100% had replication-competent virus. At wk 12, RT suppressors had significantly lower TNF-alpha levels vs non-suppressors: 0.49 pg/mL [95% CI 0.34-72] vs 0.99 pg/mL [0.72-1.37], p=0.008 and lower log D-Dimer levels: 0.91 ng/mL [95% CI 0.27-1.56] vs 1.54 ng/mL [0.91-2.16], p=0.16, Fig 1.
Persistent detectable RT HIV RNA and replication-competent virus in the first 12 wks following ART initiation is associated with higher levels of systemic inflammation and hypercoagulation. Early tissue HIV RNA viral dynamics may predict patterns of systemic inflammation and hypercoagulation even during rapid plasma virologic suppression. Larger studies of virally-suppressed patients on long-term ART are needed to confirm findings and assess additional endpoints of subclinical/clinical end-organ disease.